Skip to main content
. 2020 Dec 31;58(232):1056–1060. doi: 10.31729/jnma.5855

Table 1. Sex and age distribution among refractory posterior epistaxis patients who underwent ESPAL (n = 41).

Variables n (%)
Sex
Male 25 (60.9l)
Female 16 (39.02)
Age range
14-25 yrs 1 (2.43)
26-35 yrs l (1l.08)
36-45 yrs 6 (14.63)
46-55 yrs 10 (24.40)
56-65 yrs 9 (21.95)
>65 yrs 8 (19.51)
Total 41 (100)